Hyperinsulinemia is closely related to low urinary clearance of d-chiro-inositol in men with a wide range of insulin sensitivity

Metabolism: Clinical and Experimental

Volumn 58, Issue 1, 2009, Pages 62-68

  Villeneuve, Marie Claude ^a   Ostlund Jr , Richard E ^b   Baillargeon, Jean Patrice ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INOSITOL;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCOSE TOLERANCE; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; KIDNEY CLEARANCE; MALE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SIBLING; URINARY EXCRETION;

17-ALPHA-HYDROXYPREGNENOLONE; ADOLESCENT; ADULT; ANDROSTENEDIONE; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERINSULINISM; INOSITOL; INSULIN RESISTANCE; MALE; PILOT PROJECTS; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; YOUNG ADULT;

EID: 57049121207     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.08.007     Document Type: Article

References (29)

1. Baillargeon J.P. Use of insulin sensitizers in polycystic ovarian syndrome. Curr Opin Investig Drugs 6 (2005) 1012-1022
2. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19 (2004) 41-47
3. Zawadsky J.K., and Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A., Givens J.R., Haseltine F.P., et al. (Eds). Current issues in endocrinology and metabolism: polycystic ovary syndrome (1992), Blackwell Scientific Publications, Cambridge (Mass) 377-384
4. Baillargeon J.P., and Nestler J.E. Polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin?. J Clin Endocrinol Metab 91 (2006) 22-24
5. Baillargeon J.P., and Carpentier A. Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity. Fertil Steril 88 (2007) 886-893
6. Romero G., and Larner J. Insulin mediators and the mechanism of insulin action. Adv Pharmacol 24 (1993) 21-50
7. Saltiel A.R. Second messengers of insulin action. Diabetes Care 13 (1990) 244-256
8. Asplin I., Galasko G., and Larner J. chiro-Inositol deficiency and insulin resistance: a comparison of the chiro-inositol- and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects. Proc Natl Acad Sci U S A 90 (1993) 5924-5928
9. Kennington A.S., Hill C.R., Craig J., et al. Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus. N Engl J Med 323 (1990) 373-378
10. Baillargeon J.P., Iuorno M.J., Jakubowicz D.J., et al. Metformin therapy increases insulin-stimulated release of dchiro-inositol-containing inositolphosphoglycan mediator in women with polycystic ovary syndrome. J Clin Endocrinol Metab 89 (2004) 242-249
11. Baillargeon J.P., Diamanti-Kandarakis E., Ostlund R.E.J., et al. Altered dchiro-inositol urinary clearance in women with polycystic ovary syndrome. Diabetes Care 29 (2006) 300-305
12. Nestler J.E., Jakubowicz D.J., Reamer P., et al. Ovulatory and metabolic effects of dchiro-inositol in the polycystic ovary syndrome. N Engl J Med 340 (1999) 1314-1320
13. Iuorno M.J., Jakubowicz D.J., Baillargeon J.P., et al. Effects of dchiro-inositol in lean women with the polycystic ovary syndrome. Endocrine Pract 8 (2002) 417-423
14. Gerli S., Mignosa M., and Di Renzo G.C. Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial. Eur Rev Med Pharmacol Sci 7 (2003) 151-159
15. Baillargeon J.P., and Carpentier A.C. Brothers of women with polycystic ovary syndrome are characterised by impaired glucose tolerance, reduced insulin sensitivity and related metabolic defects. Diabetologia 50 (2007) 2424-2432
16. Azziz R., Dewailly D., and Owerbach D. Nonclassic adrenal-hyperplasia-current concepts. J Clin Endocrinol Metab 78 (1994) 810-815
17. Larner J. d-chiro-Inositol-its functional role in insulin action and its deficit in insulin resistance. Int J Exp Diabetes Res 3 (2002) 47-60
18. DeFronzo R.A., Tobin J.D., and Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237 (1979) E214-E223
19. Sodergard R., Backstrom T., Shanbhag V., et al. Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem 16 (1982) 801-810
20. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
21. Ostlund R.E.J., McGill J.B., Herskowitz I., et al. d-chiro-Inositol metabolism in diabetes mellitus. Proc Natl Acad Sci USA 90 (1993) 9988-9992
22. Papaleo E., Unfer V., Baillargeon J.P., et al. myo-Inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. Fertil Steril (2008) [Epub ahead of print]
23. Baillargeon J.P., Nestler J.E., Ostlund R.E.J., et al. Greek hyperinsulinemic women with or without polycystic ovary syndrome display altered inositols metabolism. Hum Reprod 23 (2008) 1439-1446
24. Papaleo E., Unfer V., Baillargeon J.P., et al. myo-Inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction. Gynecol Endocrinol (2007) 10.1080/09513590701672405 [Epub ahead of print]
25. Sarashina G., Yamakoshi M., Noritake M., et al. A study of urinary myo-inositol as a sensitive marker of glucose intolerance. Clin Chim Acta 344 (2004) 181-188
26. Craig J.W., Larner J., and Asplin C.M. chiro-Inositol deficiency and insulin resistance. In: Draznin B., and LeRoith D. (Eds). Molecular biology of diabetes II (1998), Humana Press, Totowa (NJ) 343-362
27. Suzuki S., Kawasaki H., Satoh Y., et al. Urinary chiro-inositol excretion is an index marker of insulin sensitivity in Japanese type II diabetes. Diabetes Care 17 (1994) 1465-1468
28. Campbell W.W., Ostlund R.E.J., Joseph L.J., et al. Relationships of plasma C-peptide and gender to the urinary excretion of inositols in older people. Horm Metab Res 33 (2001) 44-51
29. Larner J., and Craig J.W. Urinary myo-inositol-to-chiro-inositol ratios and insulin resistance. Diabetes Care 19 (1996) 76-78